These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34766524)

  • 21. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
    Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
    Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities.
    Goldstein CE; Weijer C; Taljaard M; Al-Jaishi AA; Basile E; Brehaut J; Cook CL; Grimshaw JM; Lacson E; Lindsay C; Jardine M; Dember LM; Garg AX
    Am J Kidney Dis; 2019 Nov; 74(5):659-666. PubMed ID: 31227227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical Issues in the Design and Conduct of Pragmatic Cluster Randomized Trials in Hemodialysis Care: An Interview Study With Key Stakeholders.
    Nicholls SG; Carroll K; Weijer C; Goldstein CE; Brehaut J; Sood MM; Al-Jaishi A; Basile E; Grimshaw JM; Garg AX; Taljaard M
    Can J Kidney Health Dis; 2020; 7():2054358120964119. PubMed ID: 33194212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.
    Dember LM; Archdeacon P; Krishnan M; Lacson E; Ling SM; Roy-Chaudhury P; Smith KA; Flessner MF
    J Am Soc Nephrol; 2016 Oct; 27(10):2955-2963. PubMed ID: 27401689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Targeted" consent for pragmatic clinical trials.
    Wendler D
    J Gen Intern Med; 2015 May; 30(5):679-82. PubMed ID: 25586870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incentives to participate in clinical trials: practical and ethical considerations.
    Bernstein SL; Feldman J
    Am J Emerg Med; 2015 Sep; 33(9):1197-200. PubMed ID: 26095131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
    Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
    Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Partner Perspectives Regarding Ethically and Clinically Important Aspects of Trial Design in Pragmatic Cluster Randomized Trials for Hemodialysis.
    Nicholls SG; Carroll K; Goldstein CE; Brehaut JC; Weijer C; Zwarenstein M; Dixon S; Grimshaw JM; Garg AX; Taljaard M
    Can J Kidney Health Dis; 2021; 8():20543581211032818. PubMed ID: 34367647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.
    Chi PC; Owino EA; Jao I; Bejon P; Kapulu M; Marsh V; Kamuya D
    BMC Med Ethics; 2022 Apr; 23(1):46. PubMed ID: 35443642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.
    Weinfurt KP; Hernandez AF; Coronado GD; DeBar LL; Dember LM; Green BB; Heagerty PJ; Huang SS; James KT; Jarvik JG; Larson EB; Mor V; Platt R; Rosenthal GE; Septimus EJ; Simon GE; Staman KL; Sugarman J; Vazquez M; Zatzick D; Curtis LH
    BMC Med Res Methodol; 2017 Sep; 17(1):144. PubMed ID: 28923013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.
    Garcia CJ; Haynes K; Pokorney SD; Lin ND; McMahill-Walraven C; Nair V; Parlett L; Martin D; Al-Khalidi HR; McCall D; Granger CB; Platt R; Cocoros NM
    Clin Trials; 2020 Aug; 17(4):360-367. PubMed ID: 32589056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.
    Anderson ML; Califf RM; Sugarman J;
    Clin Trials; 2015 Jun; 12(3):276-86. PubMed ID: 25733677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in pragmatic randomised trials: sources and management.
    Giraudeau B; Caille A; Eldridge SM; Weijer C; Zwarenstein M; Taljaard M
    BMC Med; 2022 Oct; 20(1):372. PubMed ID: 36303153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Challenge Trials: Ethical and Legal Issues for COVID-19 Research.
    Freckelton I
    J Law Med; 2021 Mar; 28(2):311-322. PubMed ID: 33768743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.
    Dal-Ré R; Avendaño-Solà C; de Boer A; James SK; Rosendaal FR; Stephens R; Ioannidis JPA
    J Clin Epidemiol; 2019 Oct; 114():60-71. PubMed ID: 31212001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
    Elder WG; Munk N
    J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.
    Kalkman S; van Thiel GJMW; Zuidgeest MGP; Goetz I; Pfeiffer BM; Grobbee DE; van Delden JJM;
    J Clin Epidemiol; 2017 Sep; 89():181-187. PubMed ID: 28502809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials.
    Smalley JB; Merritt MW; Al-Khatib SM; McCall D; Staman KL; Stepnowsky C
    Clin Trials; 2015 Oct; 12(5):476-84. PubMed ID: 26374687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responding to signals of mental and behavioral health risk in pragmatic clinical trials: Ethical obligations in a healthcare ecosystem.
    Ali J; Morain SR; O'Rourke PP; Wilfond B; O'Brien EC; Zigler CK; Staman KL; Weinfurt KP; Sugarman J
    Contemp Clin Trials; 2022 Feb; 113():106651. PubMed ID: 34998990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.
    Miller DG; Kim SYH; Li X; Dickert NW; Flory J; Runge CP; Relton C
    JAMA Netw Open; 2018 Dec; 1(8):e186149. PubMed ID: 30646316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.